MetLife Investment Management’s KORU Medical Systems KRMD Stock Holding History

MetLife Investment Management’s Portfolio KRMD Stock Details KRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$105K	Buy	24,276 +7,900	+48%	+$39.2K	﹤0.01%	2519
2025 Q4	$95.1K	Sell	16,376 -7,988	-33%	-$38.3K	﹤0.01%	2620
2025 Q3	$93.3K	Sell	24,364 -2,021	-8%	-$7.73K	﹤0.01%	2678
2025 Q2	$94.5K	Buy	+26,385	New	+$74.9K	﹤0.01%	2572
2023 Q3	–	Sell	-18,708	Closed	-$64.5K	–	2936
2023 Q2	$64.5K	Buy	+18,708	New	+$73.4K	﹤0.01%	2871
2020 Q3	–	Sell	-13,993	Closed	-$126K	–	2318
2020 Q2	$126K	Buy	+13,993	New	+$141K	﹤0.01%	2147

Other funds holding KRMD

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

TCM

Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simcoe Capital Spokane, Washington $109M AUM

MIM

Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return

EFMC

Empire Financial Management Company New York $442M AUM 24.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

MetLife Investment Management's KRMD Position: Q1 2026 in Review

MetLife Investment Management increased its KORU Medical Systems (KRMD) stake by 48% in Q1 2026, buying an estimated $39.2K and bringing the position to 24,276 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #2519.

MetLife Investment Management first reported a position in KRMD in Q2 2020 and has held it in 6 quarters since. The position peaked at $126K in Q2 2020. 91 funds tracked by Wall St. Rank hold KRMD as of Q1 2026.

MetLife Investment Management held 24,276 shares of KORU Medical Systems worth $105K as of Q1 2026.
MetLife Investment Management bought 7,900 KORU Medical Systems shares in Q1 2026, an estimated $39.2K.
KORU Medical Systems made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2519 holding.
MetLife Investment Management first reported a position in KORU Medical Systems in Q2 2020 and has held it in 6 quarters since.
MetLife Investment Management's KORU Medical Systems position peaked at $126K in Q2 2020.
91 funds tracked by Wall St. Rank held KORU Medical Systems as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.